168 related articles for article (PubMed ID: 24037693)
1. Screening for HIV-associated peripheral neuropathy in resource-limited settings.
Cettomai D; Kwasa JK; Birbeck GL; Price RW; Cohen CR; Bukusi EA; Kendi C; Meyer AC
Muscle Nerve; 2013 Oct; 48(4):516-24. PubMed ID: 24037693
[TBL] [Abstract][Full Text] [Related]
2. Utility of quantitative sensory testing and screening tools in identifying HIV-associated peripheral neuropathy in Western Kenya: pilot testing.
Cettomai D; Kwasa J; Kendi C; Birbeck GL; Price RW; Bukusi EA; Cohen CR; Meyer AC
PLoS One; 2010 Dec; 5(12):e14256. PubMed ID: 21170387
[TBL] [Abstract][Full Text] [Related]
3. The reliability and validity of the subjective peripheral neuropathy screen.
McArthur JH
J Assoc Nurses AIDS Care; 1998; 9(4):84-94. PubMed ID: 9658364
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a clinical screening tool for HIV-associated sensory neuropathies.
Cherry CL; Wesselingh SL; Lal L; McArthur JC
Neurology; 2005 Dec; 65(11):1778-81. PubMed ID: 16344522
[TBL] [Abstract][Full Text] [Related]
5. HIV neuropathy in pre-HAART patients and it's correlation with risk factors in Central India.
Dubey TN; Raghuvanshi SS; Sharma H; Saxena R
Neurol India; 2013; 61(5):478-80. PubMed ID: 24262448
[TBL] [Abstract][Full Text] [Related]
6. Sensory, psychological, and metabolic dysfunction in HIV-associated peripheral neuropathy: A cross-sectional deep profiling study.
Phillips TJC; Brown M; Ramirez JD; Perkins J; Woldeamanuel YW; Williams ACC; Orengo C; Bennett DLH; Bodi I; Cox S; Maier C; Krumova EK; Rice ASC
Pain; 2014 Sep; 155(9):1846-1860. PubMed ID: 24973717
[TBL] [Abstract][Full Text] [Related]
7. Early detection of peripheral neuropathy using stimulated skin wrinkling test in human immunodeficiency virus infected patients: A cross-sectional study.
Mawuntu AHP; Mahama CN; Khosama H; Estiasari R; Imran D
Medicine (Baltimore); 2018 Jul; 97(30):e11526. PubMed ID: 30045275
[TBL] [Abstract][Full Text] [Related]
8. Screening for distal sensory peripheral neuropathy in HIV-infected persons in research and clinical settings.
Marra CM; Boutin P; Collier AC
Neurology; 1998 Dec; 51(6):1678-81. PubMed ID: 9855522
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and factors associated with peripheral neuropathy among HIV infected patients in Gondar, Ethiopia: A cross-sectional study.
Adem KS; Janakiraman B; Gebremeskel BF; Chala MB; Gelaw AY; Alemu K
PLoS One; 2019; 14(1):e0211354. PubMed ID: 30695060
[TBL] [Abstract][Full Text] [Related]
10. Implementation of a validated peripheral neuropathy screening tool in patients receiving antiretroviral therapy in Mombasa, Kenya.
Mehta SA; Ahmed A; Kariuki BW; Said S; Omasete F; Mendillo M; Laverty M; Holzman R; Valentine F; Sivapalasingam S
Am J Trop Med Hyg; 2010 Sep; 83(3):565-70. PubMed ID: 20810821
[TBL] [Abstract][Full Text] [Related]
11. Over-reported peripheral neuropathy symptoms in a cohort of HIV infected and uninfected Rwandan women: the need for validated locally appropriate questionnaires.
Tumusiime DK; Musabeyezu E; Mutimurah E; Hoover DR; Shi Q; Rudakemwa E; Ndacyayisenga V; Dusingize JC; Sinayobye JD; Stewart A; Venter FW; Anastos K
Afr Health Sci; 2014 Jun; 14(2):460-7. PubMed ID: 25320598
[TBL] [Abstract][Full Text] [Related]
12. Risk modifiers for peripheral sensory neuropathy in HIV infection/AIDS.
Lopez OL; Becker JT; Dew MA; Caldararo R
Eur J Neurol; 2004 Feb; 11(2):97-102. PubMed ID: 14748769
[TBL] [Abstract][Full Text] [Related]
13. Simplification of the research diagnosis of HIV-associated sensory neuropathy.
Evans SR; Clifford DB; Kitch DW; Goodkin K; Schifitto G; McArthur JC; Simpson DM
HIV Clin Trials; 2008; 9(6):434-9. PubMed ID: 19203909
[TBL] [Abstract][Full Text] [Related]
14. Peripheral neuropathy in HIV: prevalence and risk factors.
Evans SR; Ellis RJ; Chen H; Yeh TM; Lee AJ; Schifitto G; Wu K; Bosch RJ; McArthur JC; Simpson DM; Clifford DB
AIDS; 2011 Apr; 25(7):919-28. PubMed ID: 21330902
[TBL] [Abstract][Full Text] [Related]
15. Hypertriglyceridemia in combination antiretroviral-treated HIV-positive individuals: potential impact on HIV sensory polyneuropathy.
Banerjee S; McCutchan JA; Ances BM; Deutsch R; Riggs PK; Way L; Ellis RJ
AIDS; 2011 Jan; 25(2):F1-6. PubMed ID: 21150557
[TBL] [Abstract][Full Text] [Related]
16. Is skin biopsy a predictor of transition to symptomatic HIV neuropathy? A longitudinal study.
Herrmann DN; McDermott MP; Sowden JE; Henderson D; Messing S; Cruttenden K; Schifitto G
Neurology; 2006 Mar; 66(6):857-61. PubMed ID: 16567702
[TBL] [Abstract][Full Text] [Related]
17. Continued high prevalence and adverse clinical impact of human immunodeficiency virus-associated sensory neuropathy in the era of combination antiretroviral therapy: the CHARTER Study.
Ellis RJ; Rosario D; Clifford DB; McArthur JC; Simpson D; Alexander T; Gelman BB; Vaida F; Collier A; Marra CM; Ances B; Atkinson JH; Dworkin RH; Morgello S; Grant I;
Arch Neurol; 2010 May; 67(5):552-8. PubMed ID: 20457954
[TBL] [Abstract][Full Text] [Related]
18. Prevalence, incidence and predictors of peripheral neuropathy in African adults with HIV infection within the DART trial.
Kiwuwa-Muyingo S; Kikaire B; Mambule I; Musana H; Musoro G; Gilks CF; Levin JB; Walker AS
AIDS; 2014 Nov; 28(17):2579-88. PubMed ID: 25574960
[TBL] [Abstract][Full Text] [Related]
19. Peripheral neuropathy in patients with human immunodeficiency viral infection at a tertiary hospital in Ghana.
Puplampu P; Ganu V; Kenu E; Kudzi W; Adjei P; Grize L; Käser M
J Neurovirol; 2019 Aug; 25(4):464-474. PubMed ID: 31028691
[TBL] [Abstract][Full Text] [Related]
20. Measures of small-fiber neuropathy in HIV infection.
Boger MS; Hulgan T; Haas DW; Mitchell V; Smith AG; Singleton JR; Peltier AC
Auton Neurosci; 2012 Jul; 169(1):56-61. PubMed ID: 22542355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
